Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Payables (2017 - 2025)

Catheter Precision (VTAK) has disclosed Payables for 9 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Payables fell 18.47% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, down 18.47% year-over-year, with the annual reading at $1.5 million for FY2025, 18.47% down from the prior year.
  • Payables for Q4 2025 was $1.5 million at Catheter Precision, down from $2.4 million in the prior quarter.
  • The five-year high for Payables was $14.3 million in Q3 2023, with the low at $92000.0 in Q4 2022.
  • Average Payables over 5 years is $2.5 million, with a median of $988000.0 recorded in 2021.
  • The sharpest move saw Payables skyrocketed 3018.91% in 2023, then crashed 94.21% in 2024.
  • Over 5 years, Payables stood at $988000.0 in 2021, then tumbled by 90.69% to $92000.0 in 2022, then soared by 604.35% to $648000.0 in 2023, then soared by 182.41% to $1.8 million in 2024, then dropped by 18.47% to $1.5 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $1.5 million, $2.4 million, and $2.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.